FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
20 sources checked · Left, Center, and Right included · 1h ago
Scientific American and Washington Examiner describe the same event in different terms.

MOSTLY SAME
As of August 6, 2026 at 1:56 PM, this is how Optics News reads the wording differences in this story.
20 sources across Left, Center, and Right all describe the same event.
41/99 — small wording differences, not a major framing split.
WHAT EACH SIDE EMPHASIZED
The Guardian US · Center-left · News report
WDSU New Orleans (Hearst) · Center · News report
Washington Examiner · Center-right · News report
SEE THE HEADLINES
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The m Flusiva vaccine for older people is the first made with the m RNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vacci...
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The flu shot, m Flusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
The Food and Drug Administration on Wednesday approved the first m RNA-based influenza vaccine, marking a milestone for the technology, which was first widely used during the COVID-19 pande...
The Food and Drug Administration has approved a new flu vaccine for older people, the first made with the same m RNA technology that was key to ending the COVID-19 pandemic
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The Food and Drug Administration has approved the first m RNA-based seasonal flu vaccine, which will be available this upcoming flu season.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna.
SOURCE MAP CHANGES
Aug 6, 11:59 AM: WPIX PIX11 (Nexstar, New York) joined the source map.
Aug 6, 12:19 PM: WGN-TV (Nexstar, Chicago) joined the source map.
Aug 6, 12:26 PM: Straight Arrow News joined the source map.
Aug 6, 12:34 PM: KTLA5 (Nexstar, Los Angeles) joined the source map.
Now: Wording Gap is 41/99 and story health is stable · 20 sources · all three buckets · comparable news format.